Literature DB >> 25035388

Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.

Silvia Rabar1, Martin Harker2, Norma O'Flynn2, Anthony S Wierzbicki3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25035388     DOI： 10.1136/bmj.g4356

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  73 in total

1.  A retrospective evaluation of the NHS Health Check Programme in a multi-ethnic population.

Authors:  P Carter; D H Bodicoat; M J Davies; N B Ashra; D Riley; N Joshi; A Farooqi; I Browne; K Khunti
Journal:  J Public Health (Oxf)       Date:  2015-08-27       Impact factor: 2.341

2.  Association Between Body Mass Index and Age of Presentation With Symptomatic Coronary Artery Disease.

Authors:  Syed M Atique; Bruce Shadbolt; Paul Marley; Ahmad Farshid
Journal:  Clin Cardiol       Date:  2016-07-19       Impact factor: 2.882

3.  Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.

Authors:  Gijs F N Berkelmans; Soffia Gudbjörnsdottir; Frank L J Visseren; Sarah H Wild; Stefan Franzen; John Chalmers; Barry R Davis; Neil R Poulter; Annemieke M Spijkerman; Mark Woodward; Sara L Pressel; Ajay K Gupta; Yvonne T van der Schouw; Ann-Marie Svensson; Yolanda van der Graaf; Stephanie H Read; Bjorn Eliasson; Jannick A N Dorresteijn
Journal:  Eur Heart J       Date:  2019-09-07       Impact factor: 29.983

Review 4.  Detection and treatment of atherosclerosis using nanoparticles.

Authors:  Jia Zhang; Yujiao Zu; Chathurika S Dhanasekara; Jun Li; Dayong Wu; Zhaoyang Fan; Shu Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-05-31

Review 5.  Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspective.

Authors:  Peter Yan; Eng Kiat Kevin Tan; Jason Chon Jun Choo; Choon Fong Stanley Liew; Titus Lau; David D Waters
Journal:  Singapore Med J       Date:  2016-07       Impact factor: 1.858

6.  Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: Percent reduction or target level?

Authors:  Fernando H Y Cesena; Antonio Gabriele Laurinavicius; Viviane A Valente; Raquel D Conceição; Raul D Santos; Marcio S Bittencourt
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

7.  Social Determinant Factors and their Relationship with Nutritional Pattern in Cardiovascular Patients after Hospital Discharge.

Authors:  Hassan Nazari; Davoud Vahabzadeh; Saeed Beygh Mohammadi; Leila Zarei; Masoud Ghahramani
Journal:  Maedica (Bucur)       Date:  2016-09

8.  Analysis of the Clinical Characteristics of Patients with Acute Coronary Syndrome in Different States of Renal Function.

Authors:  L-H Hu; L-J Zhang; Z-T Jin; W Yang; L-N Zhang; C-Y Lu
Journal:  West Indian Med J       Date:  2015-05-06       Impact factor: 0.171

Review 9.  Fibrates for secondary prevention of cardiovascular disease and stroke.

Authors:  Deren Wang; Bian Liu; Wendan Tao; Zilong Hao; Ming Liu
Journal:  Cochrane Database Syst Rev       Date:  2015-10-25

10.  The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.

Authors:  M Chakhtoura; W D Leslie; M McClung; A M Cheung; G El-Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2016-09-20       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.